ArticleLancet (London, England)2010
Eliminating malaria--all of them.
Article in Lancet (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02925403 (A Phase Ib Randomised, Controlled, Single-blind Study to Assess the Safety, Immunogenicity of the Malaria Vaccine Candidate R21 With Matrix-M1 Adjuvant in West African Adult Volunteers), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Phase Ib Randomised, Controlled, Single-blind Study to Assess the Safety, Immunogenicity of the Malaria Vaccine Candidate R21 With Matrix-M1 Adjuvant in West African Adult Volunteers
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Geographical variation in Plasmodium vivax relapse.Malaria journal · 2014Pooled it
- Trial
- Trial
- Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach.Malaria journal · 2023Article
- Molecular identification of vivax malaria relapse patients in the Yunnan Province based on homology analysis of the Plasmodium vivax circumsporozoite protein gene.Parasitology research · 2023Article
- Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China.Frontiers in public health · 2022Article
- Population genomics in neglected malaria parasites.Frontiers in microbiology · 2022Review
- Identification and characterization of areas of high and low risk for asymptomatic malaria infections at sub-village level in Ratanakiri, Cambodia.Malaria journal · 2018Article
- Review
- Article
- Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites.PLoS neglected tropical diseases · 2017Article
- Global Epidemiology of Plasmodium vivax.The American journal of tropical medicine and hygiene · 2016Review
- Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon.The American journal of tropical medicine and hygiene · 2016Article
- Plasmodium vivax Transmission in Africa.PLoS neglected tropical diseases · 2015Article
- Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Antimicrobial agents and chemotherapy · 2015Article
- Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India.BMC medicine · 2015Article
- Malaria Vaccines: Progressing on a Bumpy Road.EBioMedicine · 2014Article
- Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria.Malaria journal · 2014Article
- Article
- A flow cytometry-based quantitative drug sensitivity assay for all Plasmodium falciparum gametocyte stages.PloS one · 2014Article
Corrections and comments
- Comment on
- Comment on
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21035840What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.